Search the Newsreel

Why Dynatrace (DT) Is Up 9.9% After Mixed Q1, AI Launches, And Buyback Update

Harrow adds TYRVAYA's global rights to dry eye portfolio

Harrow is expanding its dry eye product portfolio by acquiring the global rights to TYRVAYA (varenicline solution) nasal spray from Viatris, Inc. This FDA-approved nasal spray, indicated for dry eye disease, was originally developed by Oyster Point Pharma. The deal involves a $30 million …

PATRIZIA SE legt Ergebnisse für das zweite Quartal und das erste Halbjahr zum 30. Juni 2026 vor

Patrizia steigert Gewinn kräftig - Prognose 2026 steht - boerse.de

Theravance Biopharma Q2 2026: Viatris collaboration revenue $20.7M; net loss $5.9M; $388M cash

Theravance Biopharma reported its Q2 2026 financial results, including $20.7 million in revenue from its Viatris collaboration and a GAAP net loss of $5.9 million, with $387.7 million in cash and marketable securities. The company highlighted strong YUPELRI performance, a pending acquisition by Zymeworks, …

Patria Investments Ltd's Dividend Analysis

This article first appeared on GuruFocus. Assessing the Upcoming Payout and Long-Term Sustainability Patria Investments Ltd (NASDAQ:PAX) recently announced a total dividend of $0.16 per share, with the ex-dividend date set for 2026-08-10. This upcoming payment, which includes a cash dividend of $0.16 per …

Truist Adjusts Price Target on Patrick Industries to $108 From $113, Maintains Buy Rating

Truist has adjusted its price target for Patrick Industries (PATK) to $108, down from $113, while reiterating a Buy rating on the stock. This update comes as part of ongoing analyst coverage for the recreational vehicle, marine, powersports, and housing markets component provider. The …

Dimensional Fund Advisors LP Has $8.67 Million Stake in OrthoPediatrics Corp. $KIDS

Dimensional Fund Advisors LP reduced its stake in OrthoPediatrics Corp. (NASDAQ:KIDS) by 12.2% in the first quarter, though it still holds 546,626 shares valued at $8.67 million. Institutional investors collectively own 69.05% of the stock. Analysts generally maintain a "Moderate Buy" rating for OrthoPediatrics, …

Janus Henderson Group PLC Sells 20,347 Shares of Patrick Industries, Inc. $PATK

Janus Henderson Group PLC significantly reduced its stake in Patrick Industries (NASDAQ:PATK) by 58.6% in the first quarter, selling 20,347 shares and retaining 14,365 shares valued at $1.6 million. Despite this, institutional investors collectively own 93.29% of the company, and analysts maintain a "Moderate …

Atrium Therapeutics, Inc. (RNA) Stock Analysis: Exploring a Potential 102.59% Upside in the Booming RNA Therapeutics Market

Atrium Therapeutics, Inc. (RNA) is a biotechnology company focused on RNA therapeutics for cardiomyopathies, attracting investor attention despite its current stock price near its 52-week low. Analysts project a potential upside of 102.59%, with an average target price of $25.00, supported by a strong …

Warum Viatris (VTRS) nach der Anhebung der Prognose und dem Abschluss eines Aktienrückkaufs im Wert von 1,15 Milliarden US-Dollar um 6,4 % nachgibt

Why Viatris (VTRS) Is Down 6.4% After Boosting Guidance And Completing A $1.15 Billion Buyback

Viatris Inc. recently reported higher Q2 and year-to-date revenues, returned to net income, raised its full-year 2026 revenue guidance to US$14.75 billion, and completed a US$1.15 billion share repurchase program. Despite these positive developments, including a new FDA-approved contraceptive patch and reaffirmed dividend, the …

Yatra Online Inc to report Q1FY27 results on Aug 12

Patrick Industries (PATK) Completes Buyback As Earnings Rise On Flat Sales Is Its Strategy Shifting?

Patrick Industries (PATK) recently completed a significant share buyback program while reporting increased earnings on flat sales for the second quarter. This move, coupled with improved profitability, suggests a strategic shift towards capital returns and earnings per share growth rather than pure top-line revenue …

Viatris (VTRS) Is Down 6.4% After Raising 2026 Guidance And Completing Major Buyback Program

In early August 2026, Viatris Inc. reported higher second-quarter and year-to-date revenues, a six-month return to net profitability, raised its 2026 earnings guidance midpoint to US$14.75 billion, completed a US$1.15 billion share repurchase program covering 8.7% of shares, and affirmed a US$0.12 quarterly dividend. …

Trading Systems Reacting to (DT) Volatility

This article analyzes Dynatrace Inc. (NYSE: DT) stock, highlighting strong near and mid-term sentiment but a weak long-term outlook. It identifies no clear price positioning signal and compelling upside potential due to the absence of resistance levels above the current price. The analysis includes …

Viatris (VTRS) Stock May Be Below Fair Value Despite FDA Patch Approval

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Viatris stock has delivered a strong 76.1% return over the past year, and the broader valuation checks still indicate the shares may be …

Patrick Industries, Inc. Revenue Breakdown – LS:873181

Patrick Industries, Inc. generated €3.36 billion in revenue last year, with its Manufacturing segment contributing the most at €2.52 billion. The majority of its revenue, €3.36 billion, came from operations in the United States and Canada. These figures indicate a slight decrease from the …

Viatris (VTRS) Raises 2026 Guidance, Is The 11% Gap Below Fair Value Enough?

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Viatris raises 2026 guidance alongside completed buyback and fresh product approval Viatris (VTRS) has given investors a busy early August, pairing raised 2026 revenue guidance …

ETFs Investing in Patrick Industries, Inc. Stocks

This article lists various Exchange Traded Funds (ETFs) that hold stocks of Patrick Industries, Inc. (PK2), providing details such as market value, weight, issuer, management style, focus, expense ratio, and AUM for each ETF. The information helps investors understand which funds offer exposure to …

Viatris (VTRS) Stock Sees Modest Fair Value Lift After Q1 Results And Pipeline Progress

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. The latest research on Viatris centers on a revised price target of US$22 per share and what that figure implies for investors following …

Amundi Decreases Position in AptarGroup, Inc. $ATR

Amundi significantly reduced its stake in AptarGroup, Inc. (NYSE:ATR) by 70.9% in the first quarter, selling 19,646 shares and retaining 8,074 shares valued at approximately $1.02 million. Despite this, institutional investors still hold a substantial 88.52% of the company's stock. AptarGroup has seen insider …

Discipline and Rules-Based Execution in ATRC Response

This article analyzes Atricure Inc. (NASDAQ: ATRC), highlighting strong near and mid-term sentiment but a weak long-term outlook. It provides AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels. The analysis also includes multi-timeframe signal analysis, showing support and …

AptarGroup, Inc. (ATR) Stock Forecasts

Argus has lowered its target price for AptarGroup, Inc. (ATR) to $150.00 from its current price of $135.42. AptarGroup, headquartered in Crystal Lake, Illinois, is a leading global supplier of dispensing systems for consumer goods and pharmaceutical markets. The report was published on August …

H.C. Wainwright Initiates Atrium Therapeutics(RNA.US) With Buy Rating, Announces Target Price $25

H.C. Wainwright has initiated coverage on Atrium Therapeutics (RNA.US) with a Buy rating. The firm has set a target price of $25 for the company's stock. This new coverage and price target suggest a positive outlook from H.C. Wainwright on Atrium Therapeutics' future performance.

Gayatri Projects Ltd is Rated Sell

Dynatrace Inc (DT) Stock News Today

This article provides current stock news for Dynatrace Inc (DT), including its stock price, market capitalization, and P/E ratio. It indicates that more news, earnings reports, analyst ratings, and key developments will be available soon. The page also offers general information about Dynatrace and …

Patriot National Bancorp (PNBK) Q3 2025 earnings summary

Patriot National Bancorp (PNBK) reported a significant improvement in Q3 2025 with a net loss of $2.7 million, compared to a $27.0 million loss in Q3 2024. This improvement was supported by over $90 million raised from three major equity issuances in 2025, which …

ATRenew (RERE) Could Be 40% Undervalued On Hong Kong Global Recommerce Launch

ATRenew (NYSE:RERE) has initiated a significant international expansion with its Hong Kong launch, introducing the ReRe consumer brand, its first overseas ReRe Store, and the FoneSquare B2B marketplace. This move comes as the company is considered 39.8% undervalued, with a fair value of $7.56 …

Notícias das Ações da Patria Investments Ltd (PAX)

Matrix Service Co (MTRX) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Matrix Service Co (MTRX), detailing its current earnings forecast score, average price target from analysts, and a comparison with peers in the Construction & Engineering industry. It also includes anticipated future revenue and EPS figures, alongside a …

Patrick Industries, Inc. (NASDAQ:PATK) Given Average Rating of "Moderate Buy" by Brokerages

Patrick Industries, Inc. (NASDAQ:PATK) has received an average "Moderate Buy" rating from nine brokerages, with six recommending a buy, two a hold, and one a sell. The average 12-month price target set by these analysts is $116.25. The company recently reported strong quarterly results, …

Atrium Mortgage Investment (TSX:AI) Stock Caught Between Dividend Cover And Portfolio Shrinkage

Two AtriCure Directors Trimmed Shares After a Strong Quarter. Here's What Matters for Investors

Two AtriCure directors, including Maggie Yuen, sold shares after a strong second quarter where the company reported 13% revenue growth and raised its full-year outlook. Yuen sold 3,500 shares, reducing her direct equity stake by 20%, though the timing of sales by multiple directors …

Dynatrace Q1 Earnings Call Highlights

Key Points Interested in Dynatrace, Inc.? Here are five stocks we like better. Dynatrace exceeded Q1 guidance: ARR rose 17% year over year to $2.14 billion, while revenue reached $555 million and non-GAAP EPS was $0.48. Net new ARR increased 66%, supported by record …

Viatris (VTRS) Stock Looks Stuck Between Higher Guidance And Wider Losses